mhurhangee/patent-ind-claim-en huggingface dataset:
A method for modifying an image, comprising: displaying in a display region an image, the image comprising a portion of an object (DB1, DB2, DB3, DB4), wherein the object can be scrolled in a first object direction and in a second object direction being opposite to the first object direction and wherein the object includes an edge (DT) and a plurality of items; detect a drag operation in which an operating member moves in the first direction along the touch panel; if, during the drag operation, the edge of the display object has not reached die region of die display, scroll the display object in the first direction within the region of the display; if, during the drag operation, the edge of the display object has reached the region of the display, the display object is not moved any farther in the first direction; detect, during the drag operation, an overdrag operation in which the operating member moves in the first direction at a time after the edge of the display object has reached the region of the display; and in response to detecting the overdrag operation, display a graphic that overlaps at least one of the plurality of items in the display region and comprises a curved shape displayed in a direction corresponding to a direction of the overdrag operation, wherein a degree of curvature of the curved shape is modified in response to detecting the overdrag operation, and wherein the graphic is faded-out if it is determined that an operation point of the overdrag operation is not within a predetermined range. displaying in a display region an image, the image comprising a portion of an object (DB1, DB2, DB3, DB4), wherein the object can be scrolled in a first object direction and in a second object direction being opposite to the first object direction and wherein the object includes an edge (DT) and a plurality of items; detect a drag operation in which an operating member moves in the first direction along the touch panel; if, during the drag operation, the edge of the display object has not reached die region of die display, scroll the display object in the first direction within the region of the display; if, during the drag operation, the edge of the display object has reached the region of the display, the display object is not moved any farther in the first direction; detect, during the drag operation, an overdrag operation in which the operating member moves in the first direction at a time after the edge of the display object has reached the region of the display; and in response to detecting the overdrag operation, display a graphic that overlaps at least one of the plurality of items in the display region and comprises a curved shape displayed in a direction corresponding to a direction of the overdrag operation, wherein a degree of curvature of the curved shape is modified in response to detecting the overdrag operation, and wherein the graphic is faded-out if it is determined that an operation point of the overdrag operation is not within a predetermined range.
A 2-shaft gas turbine with an inner bleed structure comprising: a compressor that compresses and discharges air; a combustor that combusts compressed air compressed by the compressor and fuel to generate combustion gas; a high pressure turbine connected to the compressor with a first rotating shaft and driven by the combustion gas generated by the combustor ; a low pressure turbine driven by the combustion gas exhausted from the high pressure turbine and connected with a second rotating shaft ; an inner casing located between the compressor and the high pressure turbine and installed at the outer side of the first rotating shaft ; and a cavity formed between the inner side of the inner casing and the outer side of the first rotating shaft ; whereby a slit for leading part of the compressed air to the cavity is formed between a wall surface of a rotor wheel of the compressor equipped with the last stage rotor of the compressor which is connected to the first rotating shaft and end of the inner casing , a bleed hole for leading part of the compressed air after flowing down the last stage of the compressor to the cavity is formed in the inner casing at a position on a downstream side of the last stage of the compressor , an inducer is formed in the first rotating shaft , and characterised in that seals for sealing the compressed air are not present in an air path route, in which the compressed air flows, from the slit to the inducer . a compressor that compresses and discharges air; a combustor that combusts compressed air compressed by the compressor and fuel to generate combustion gas; a high pressure turbine connected to the compressor with a first rotating shaft and driven by the combustion gas generated by the combustor ; a low pressure turbine driven by the combustion gas exhausted from the high pressure turbine and connected with a second rotating shaft ; an inner casing located between the compressor and the high pressure turbine and installed at the outer side of the first rotating shaft ; and a cavity formed between the inner side of the inner casing and the outer side of the first rotating shaft ; whereby a slit for leading part of the compressed air to the cavity is formed between a wall surface of a rotor wheel of the compressor equipped with the last stage rotor of the compressor which is connected to the first rotating shaft and end of the inner casing , a bleed hole for leading part of the compressed air after flowing down the last stage of the compressor to the cavity is formed in the inner casing at a position on a downstream side of the last stage of the compressor , an inducer is formed in the first rotating shaft , and characterised in that seals for sealing the compressed air are not present in an air path route, in which the compressed air flows, from the slit to the inducer .
Antibodies against phosphorylcholine (PC) for use in a method of curing, treating, preventing, and/or reducing the risk of rheumatoid arthritis in a mammal, wherein the antibodies against PC are used in a combination therapy with one or more biologic agents selected from a tumor necrosis factor alpha (TNFα) blocker selected from the group consisting of etanercept, infliximab, adalimumab, or the anti-B cell antibody rituximab.
A method of manufacturing a sorbent material for collecting petroleum and petroleum products, comprising the steps of saturating a basalt fiber canvas with a hydrophobizing liquid and subsequently drying the same, characterized in that basalt fibers having a diameter of 0.2 - 2 microns and a density not exceeding 20 - 25 kg/m 3 are used as the basalt fibers of the canvas, the canvas is first fluffed, prior to saturation, using compressed air until a density of 12 - 15 kg/m 3 is reached, the saturation with a hydrophobizing liquid is performed by introducing the hydrophobizing liquid into the pre-fluffed basalt fibers of the canvas in the form of aerosol particles via compressed air, and the subsequent drying of the saturated canvas is performed using compressed air.
An article, comprising: a plurality of particles, at least about 90% of the particles each comprising an oligonucleotide tag covalently bonded thereto, the oligonucleotide tag comprising at least 2 primer sites and at least 2 barcode regions unique to the oligonucleotide tag, wherein at least about 90% of the particles are distinguishable from the other particles of the plurality of particles on the basis of the barcode regions of the oligonucleotide tag, wherein the plurality of particles is contained within a plurality of microfluidic droplets, and wherein the oligonucleotide tag further comprises a random hexanucleotide and a photo-cleavable linker. a plurality of particles, at least about 90% of the particles each comprising an oligonucleotide tag covalently bonded thereto, the oligonucleotide tag comprising at least 2 primer sites and at least 2 barcode regions unique to the oligonucleotide tag, wherein at least about 90% of the particles are distinguishable from the other particles of the plurality of particles on the basis of the barcode regions of the oligonucleotide tag, wherein the plurality of particles is contained within a plurality of microfluidic droplets, and wherein the oligonucleotide tag further comprises a random hexanucleotide and a photo-cleavable linker.
A computer-implemented method of identifying treatment relevant neoepitopes for use in guided immunotherapy of a patient diagnosed with a tumour, comprising: receiving omics data for tumour cells in a first and second location in the patient, wherein the first and second locations are different anatomical locations, and wherein the omics data is obtained using nucleic acid sequencing, RNA sequencing, protein sequencing or mass spectroscopy based sequencing; using the omics data to determine respective neoepitopes in the tumour cells of the first and second locations; filtering the respective neoepitopes against matched normal omics data; further filtering the respective neoepitopes against an HLA-type of the patient comprising: determining the HLA-type of the patient; calculating binding affinities of the respective neoepitopes to the determined HLA-type of the patient; selecting high-affinity neoepitopes for the first and second locations that have a binding affinity to the determined HLA-type of the patient of less than 500 nM; and identifying, from the high-affinity neoepitopes in the tumour cells of the first and second locations, treatment relevant neoepitopes sharing at least one of a group attribute, a location attribute, a function attribute, a metabolic attribute, and/or a pathway attribute. receiving omics data for tumour cells in a first and second location in the patient, wherein the first and second locations are different anatomical locations, and wherein the omics data is obtained using nucleic acid sequencing, RNA sequencing, protein sequencing or mass spectroscopy based sequencing; using the omics data to determine respective neoepitopes in the tumour cells of the first and second locations; filtering the respective neoepitopes against matched normal omics data; further filtering the respective neoepitopes against an HLA-type of the patient comprising: determining the HLA-type of the patient; calculating binding affinities of the respective neoepitopes to the determined HLA-type of the patient; selecting high-affinity neoepitopes for the first and second locations that have a binding affinity to the determined HLA-type of the patient of less than 500 nM; and identifying, from the high-affinity neoepitopes in the tumour cells of the first and second locations, treatment relevant neoepitopes sharing at least one of a group attribute, a location attribute, a function attribute, a metabolic attribute, and/or a pathway attribute. determining the HLA-type of the patient; calculating binding affinities of the respective neoepitopes to the determined HLA-type of the patient; selecting high-affinity neoepitopes for the first and second locations that have a binding affinity to the determined HLA-type of the patient of less than 500 nM; and identifying, from the high-affinity neoepitopes in the tumour cells of the first and second locations, treatment relevant neoepitopes sharing at least one of a group attribute, a location attribute, a function attribute, a metabolic attribute, and/or a pathway attribute.
A method for distributed foveated rendering between a remote computer and an end user device that presents images on a display based on user gaze, the method implemented on the end user device and comprising: receiving, from the remote computer , a background image and a foreground image, wherein: the background image has a lower resolution than the foreground image and has first dimensions that are smaller than an image display region of the display, and the foreground image corresponds to and has second dimensions that are equal to a foveated region located within the image display region and containing the location of the gaze of the user on the display; generating a composite image by scaling up the background image to the image display region and by overlaying the foreground image based on gaze data of a user of the end user device , wherein the positioning of the foreground image is based on the location of the gaze of the user; and presenting the composite image in the image display region of the display; characterized by further comprising: f determining a brightness difference between a first pixel from the overlaid foreground image and a second pixel from the scaled up background image, wherein the first pixel and the second pixel have a same pixel location in the composite image and correspond to a same object visible in the composite image and spanning the high resolution and low resolution regions of the composite image; adjusting a brightness of the first pixel to reduce the brightness difference when the brightness difference is larger than a predefined threshold; warping the composite image ; and presenting the composite image by presenting the warped composite image . the background image has a lower resolution than the foreground image and has first dimensions that are smaller than an image display region of the display, and the foreground image corresponds to and has second dimensions that are equal to a foveated region located within the image display region and containing the location of the gaze of the user on the display; generating a composite image by scaling up the background image to the image display region and by overlaying the foreground image based on gaze data of a user of the end user device , wherein the positioning of the foreground image is based on the location of the gaze of the user; and presenting the composite image in the image display region of the display; characterized by further comprising: f determining a brightness difference between a first pixel from the overlaid foreground image and a second pixel from the scaled up background image, wherein the first pixel and the second pixel have a same pixel location in the composite image and correspond to a same object visible in the composite image and spanning the high resolution and low resolution regions of the composite image; adjusting a brightness of the first pixel to reduce the brightness difference when the brightness difference is larger than a predefined threshold; warping the composite image ; and presenting the composite image by presenting the warped composite image .
Migalastat or salt thereof for use in a method of reducing the risk of a cerebrovascular (CBV) event in a patient having Fabry disease, the method comprising administering to the patient a formulation comprising an effective amount of the migalastat or salt thereof every other day for at least 2 years, wherein the effective amount is about 100 mg to about 150 mg free base equivalent (FBE).
A device to be charged , comprising: a battery ; a wireless reception circuit , configured to receive an electromagnetic signal from a wireless charging device and convert the electromagnetic signal into output voltage and output current of the wireless reception circuit , wherein the output voltage is a pulsating waveform voltage and a period of the output current varies with a frequency or a multiple of the frequency of an AC input into the wireless charging device ; a first charging channel , through which the output voltage and the output current of the wireless reception circuit are received and provided to the battery for charging; a detecting circuit , configured to detect at least one of the output voltage and the output current of the wireless reception circuit ; and a first communication control circuit , configured to conduct wireless communication with the wireless charging device according to at least one of the output voltage and the output current of the wireless reception circuit detected by the detecting circuit , whereby the wireless charging device is configured to adjust transmission power thereof to make at least one of the output voltage and the output current of the wireless reception circuit match a present charging stage of the battery . a battery ; a wireless reception circuit , configured to receive an electromagnetic signal from a wireless charging device and convert the electromagnetic signal into output voltage and output current of the wireless reception circuit , wherein the output voltage is a pulsating waveform voltage and a period of the output current varies with a frequency or a multiple of the frequency of an AC input into the wireless charging device ; a first charging channel , through which the output voltage and the output current of the wireless reception circuit are received and provided to the battery for charging; a detecting circuit , configured to detect at least one of the output voltage and the output current of the wireless reception circuit ; and a first communication control circuit , configured to conduct wireless communication with the wireless charging device according to at least one of the output voltage and the output current of the wireless reception circuit detected by the detecting circuit , whereby the wireless charging device is configured to adjust transmission power thereof to make at least one of the output voltage and the output current of the wireless reception circuit match a present charging stage of the battery .
A bioink supply system for a 3D printing system, comprising: a hydrogel storage part ; a cell storage part ; a mixing part configured to receive and mix a hydrogel and a cell solution from the hydrogel storage part and the cell storage part ; characterized in that the bioink supply system further comprises a sensor part configured to measure a level of bioink inside a syringe ; and a controller configured to receive a signal from the sensor part and maintain a constant level of the bioink inside the syringe by operating or stopping a pump for supplying the bioink to the syringe , wherein the mixing part supplies, to the syringe , the bioink prepared by mixing the hydrogel and the cell solution; wherein the cell storage part is maintained under conditions of CO 2 concentration of 5%, temperature of 37°C, and pH of 7 to 7.5. a hydrogel storage part ; a cell storage part ; a mixing part configured to receive and mix a hydrogel and a cell solution from the hydrogel storage part and the cell storage part ; characterized in that the bioink supply system further comprises a sensor part configured to measure a level of bioink inside a syringe ; and a controller configured to receive a signal from the sensor part and maintain a constant level of the bioink inside the syringe by operating or stopping a pump for supplying the bioink to the syringe , wherein the mixing part supplies, to the syringe , the bioink prepared by mixing the hydrogel and the cell solution; wherein the cell storage part is maintained under conditions of CO 2 concentration of 5%, temperature of 37°C, and pH of 7 to 7.5.
Valet parking system for automatically bringing a vehicle to an allocated parking space inside a predefined parking area , comprising a central control unit and a parking space monitoring system having at least one parking space sensor arranged in a stationary manner, wherein the parking space monitoring system is designed to capture the occupancy status of the parking spaces in the parking area and to transmit the current occupancy status to the central control unit and/or to locate vehicles autonomously driving or waiting inside the predefined parking area and to transmit information relating to the current vehicle position to the central control unit , wherein the central control unit is designed to allocate a free parking space to a vehicle and to transmit information to the vehicle , with the result that the vehicle can be autonomously brought to the allocated parking space along a trajectory , wherein a free parking space is allocated to the vehicle depending on the geometrical dimensions, in particular the height, of the vehicle , characterized in that a free parking space is allocated to the vehicle in such a manner that concealment of the capture region of the parking space sensors of the parking space monitoring system by the parked vehicle is minimized. wherein the central control unit is designed to allocate a free parking space to a vehicle and to transmit information to the vehicle , with the result that the vehicle can be autonomously brought to the allocated parking space along a trajectory , wherein a free parking space is allocated to the vehicle depending on the geometrical dimensions, in particular the height, of the vehicle , characterized in that a free parking space is allocated to the vehicle in such a manner that concealment of the capture region of the parking space sensors of the parking space monitoring system by the parked vehicle is minimized.
An operating method of a memory controller , comprising: Receiving from a memory device a first read data (HDR1) read by the memory device and a second conversion information (SYD2, CHDR2), the second conversion information (SYD2, CHDR2) comprising data obtained by converting a second read data (HDR2) read by the memory device based on a linear operation, wherein the linear operation comprises only XOR and is executed by a syndrome former and wherein the linear operation is data compression action, and the first read data (HDR1) and the second read data (HDR2) comprising BCH code word data read from same memory cells, wherein the first read data (HDR1) and the second read data (HDR2) are hard decision read data; converting the first read data (HDR1) based on the linear operation to generate a first conversion information (SYD1, CHDR1); performing a logical operation on the first conversion information (SYD1, CHDR1) and the second conversion information (SYD2, CHDR2) to generate an operation information (CXDR1); performing an inverse operation of the linear operation on the operation information (CXDR1) by BCH decoding the operation information (CXDR1) to generate a reliability information (WRB) indicating a position of an error in the first read data (HDR1), wherein the BCH decoding comprises executing a Berlekamp Massey algorithm and a Chien Search; and correcting the indicated error of the first read data (HDR1) based on the first read data (HDR1) and the reliability information (WRB). Receiving from a memory device a first read data (HDR1) read by the memory device and a second conversion information (SYD2, CHDR2), the second conversion information (SYD2, CHDR2) comprising data obtained by converting a second read data (HDR2) read by the memory device based on a linear operation, wherein the linear operation comprises only XOR and is executed by a syndrome former and wherein the linear operation is data compression action, and the first read data (HDR1) and the second read data (HDR2) comprising BCH code word data read from same memory cells, wherein the first read data (HDR1) and the second read data (HDR2) are hard decision read data; converting the first read data (HDR1) based on the linear operation to generate a first conversion information (SYD1, CHDR1); performing a logical operation on the first conversion information (SYD1, CHDR1) and the second conversion information (SYD2, CHDR2) to generate an operation information (CXDR1); performing an inverse operation of the linear operation on the operation information (CXDR1) by BCH decoding the operation information (CXDR1) to generate a reliability information (WRB) indicating a position of an error in the first read data (HDR1), wherein the BCH decoding comprises executing a Berlekamp Massey algorithm and a Chien Search; and correcting the indicated error of the first read data (HDR1) based on the first read data (HDR1) and the reliability information (WRB).